ATIP vs. BRTX, MGRX, OTRK, SSY, BGLC, ACON, DHAC, VSEE, NIVF, and BACK
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), Vsee Health (VSEE), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry.
ATI Physical Therapy vs.
ATI Physical Therapy (NYSE:ATIP) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, community ranking, dividends, profitability and analyst recommendations.
72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are held by institutional investors. 3.3% of ATI Physical Therapy shares are held by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
ATI Physical Therapy has a net margin of -7.79% compared to BioRestorative Therapies' net margin of -2,697.08%. ATI Physical Therapy's return on equity of 0.00% beat BioRestorative Therapies' return on equity.
ATI Physical Therapy has a beta of -0.23, meaning that its share price is 123% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 77.73, meaning that its share price is 7,673% more volatile than the S&P 500.
ATI Physical Therapy received 13 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
BioRestorative Therapies has a consensus target price of $18.00, suggesting a potential upside of 1,021.50%. Given BioRestorative Therapies' stronger consensus rating and higher possible upside, analysts clearly believe BioRestorative Therapies is more favorable than ATI Physical Therapy.
BioRestorative Therapies has lower revenue, but higher earnings than ATI Physical Therapy. BioRestorative Therapies is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
In the previous week, BioRestorative Therapies had 5 more articles in the media than ATI Physical Therapy. MarketBeat recorded 5 mentions for BioRestorative Therapies and 0 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of 0.00 beat BioRestorative Therapies' score of -0.67 indicating that ATI Physical Therapy is being referred to more favorably in the media.
Summary
BioRestorative Therapies beats ATI Physical Therapy on 10 of the 18 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
This page (NYSE:ATIP) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy ATIP Stock Free ATIP Stock Alerts